DrugDashboards

Peg-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate And Ascorbic Acid

Peg-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate And Ascorbic Acid · Kit · Teva Pharmaceuticals USA, Inc.

NDC 00093-3560-26 · 2 CARTON in 1 CARTON / 1 KIT in 1 CARTON * 1 L in 1 POUCH * 1 L in 1 POUCH * 1 L in 1 POUCH · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $81.45 per unit over the past year. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$50.00$100.00Nov 2020Sep 2026$81.45
65 price points · per EASource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$96.80
Reported to Texas DSHS · 2026 annual filing · Teva Pharmaceuticals USA, Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$137,864
1,853 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

30Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid (other) in the next 90 days

price up 5% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA090145
TE code
AA
Approval date
Jan 25, 2012
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class III · TerminatedJul 2, 2024
    Novel Laboratories, Inc. d.b.a Lupin SomersetDefective container: potential for non-sealed pouches which can lead to product leakage.

Manufacturers of Peg-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate And Ascorbic Acid (Kit)

LabelerStrengthFirst seenLast seen
Teva Pharmaceuticals USA, Inc.Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Peg-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate And Ascorbic Acid — NDC 00093-3560-26," retrieved September 3, 2026, https://drugdashboards.com/drug/00093356026.

Free to cite with attribution — see how the data is put together.